Dmitri Krysko
Cited by
Cited by
Immunogenic cell death and DAMPs in cancer therapy
DV Krysko, AD Garg, A Kaczmarek, O Krysko, P Agostinis, ...
Nature reviews cancer 12 (12), 860-875, 2012
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance
A Kaczmarek, P Vandenabeele, DV Krysko
Immunity 38 (2), 209-223, 2013
Apoptosis and necrosis: detection, discrimination and phagocytosis
DV Krysko, TV Berghe, K D’Herde, P Vandenabeele
Methods 44 (3), 205-221, 2008
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
JP Friedmann Angeli, DV Krysko, M Conrad
Nature Reviews Cancer 19 (7), 405-414, 2019
Consensus guidelines for the detection of immunogenic cell death
O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ...
Oncoimmunology 3 (9), e955691, 2014
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
AD Garg, DV Krysko, T Verfaillie, A Kaczmarek, GB Ferreira, T Marysael, ...
The EMBO journal 31 (5), 1062-1079, 2012
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
DV Krysko, P Agostinis, O Krysko, AD Garg, C Bachert, BN Lambrecht, ...
Trends in immunology 32 (4), 157-164, 2011
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation
AD Garg, D Nowis, J Golab, P Vandenabeele, DV Krysko, P Agostinis
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (1), 53-71, 2010
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
B Hassannia, B Wiernicki, I Ingold, F Qu, S Van Herck, YY Tyurina, ...
The Journal of clinical investigation 128 (8), 3341-3355, 2018
Molecular mechanisms and pathophysiology of necrotic cell death
N Vanlangenakker, TV Berghe, DV Krysko, N Festjens, P Vandenabeele
Current molecular medicine 8 (3), 207-220, 2008
ER stress-induced inflammation: does it aid or impede disease progression?
AD Garg, A Kaczmarek, O Krysko, P Vandenabeele, DV Krysko, ...
Trends in molecular medicine 18 (10), 589-598, 2012
Clearance of apoptotic and necrotic cells and its immunological consequences
DV Krysko, K D’Herde, P Vandenabeele
Apoptosis 11 (10), 1709-1726, 2006
Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity
TL Aaes, A Kaczmarek, T Delvaeye, B De Craene, S De Koker, ...
Cell reports 15 (2), 274-287, 2016
Molecular and translational classifications of DAMPs in immunogenic cell death
AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, BS Pedro, J Manuel, ...
Frontiers in immunology 6, 169354, 2015
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
AD Garg, DV Krysko, P Vandenabeele, P Agostinis
Cancer Immunology, Immunotherapy 61, 215-221, 2012
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
R Alzeibak, TA Mishchenko, NY Shilyagina, IV Balalaeva, MV Vedunova, ...
Journal for immunotherapy of cancer 9 (1), 2021
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
AD Garg, AM Dudek, GB Ferreira, T Verfaillie, P Vandenabeele, ...
Autophagy 9 (9), 1292-1307, 2013
Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production
G Brouckaert, M Kalai, DV Krysko, X Saelens, D Vercammen, M Ndlovu, ...
Molecular biology of the cell 15 (3), 1089-1100, 2004
Determination of apoptotic and necrotic cell death in vitro and in vivo
TV Berghe, S Grootjans, V Goossens, Y Dondelinger, DV Krysko, ...
Methods 61 (2), 117-129, 2013
Connexin-related signaling in cell death: to live or let die?
E Decrock, M Vinken, E De Vuyst, DV Krysko, K D'herde, T Vanhaecke, ...
Cell Death & Differentiation 16 (4), 524-536, 2009
The system can't perform the operation now. Try again later.
Articles 1–20